• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of adjunctive intracoronary adenosine on myocardial ischemia, hemodynamic function and left ventricular performance during percutaneous transluminal coronary angioplasty: clinical access to ischemic preconditioning?

作者信息

Heidland U E, Heintzen M P, Michel C J, Strauer B E

机构信息

School of Internal Medicine, Department of Cardiology, Pneumology and Angiology, Heinrich Heine University, Düsseldorf, Germany.

出版信息

Coron Artery Dis. 2000 Jul;11(5):421-8. doi: 10.1097/00019501-200007000-00007.

DOI:10.1097/00019501-200007000-00007
PMID:10895409
Abstract

BACKGROUND

Ischemic preconditioning has been defined as a mechanism that renders the heart more resistant to subsequent ischemia. Adenosine plays an important role in the pathogenesis of ischemic preconditioning.

OBJECTIVE

To assess whether intracoronary administration of adenosine prevents the deterioration of left ventricular performance and hemodynamic function by allowing adaptation to myocardial ischemia in the setting of percutaneous transluminal coronary angioplasty (PTCA).

DESIGN

This was a prospectively randomized doubly blinded trial.

METHODS

We investigated 20 patients undergoing PTCA of the left anterior descending coronary artery supplying myocardium with normal left ventricular function in the setting of stable angina pectoris. Patients were randomly allocated to be administered adenosine intracoronarily (20 mg/10 min) or an equal amount of saline, providing a control population. Results of standardized chest pain questionnaires, tolerated inflation times, ST-segment shifts, left ventricular and aortic pressures, isovolumetric phase indexes, and indexes of volume and ejection fraction during the course of PTCA between the two groups were compared.

RESULTS

Patients administered adenosine tolerated significantly longer balloon-inflation times (188 +/- 41 versus 153 +/- 36 s; P = 0.03), which were associated with less pronounced signs of ischemia, and exhibited less deterioration of isovolumetric phase indexes during PTCA. Deterioration of left ventricular ejection fraction was slightly less severe with adenosine (72 +/- 5% before PTCA versus 64 +/- 6% during angioplasty) than it was for the control group (71 +/- 7% before PTCA versus 60 +/- 7% during angioplasty; P = 0.11).

CONCLUSIONS

Intracoronary application of adenosine prior to coronary angioplasty increases tolerance of ischemia and prevents deterioration of left ventricular hemodynamics during ischemia. One potential explanation of these results is that induction of ischemic preconditioning took place.

摘要

相似文献

1
Effect of adjunctive intracoronary adenosine on myocardial ischemia, hemodynamic function and left ventricular performance during percutaneous transluminal coronary angioplasty: clinical access to ischemic preconditioning?
Coron Artery Dis. 2000 Jul;11(5):421-8. doi: 10.1097/00019501-200007000-00007.
2
Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exogenous adenosine.
Am Heart J. 2000 Nov;140(5):813-20. doi: 10.1067/mhj.2000.110287.
3
[Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].经冠状动脉内注射双嘧达莫在经皮腔内冠状动脉成形术(PTCA)期间的药理心肌保护作用:血流动力学、收缩功能及心室动态变化
Z Kardiol. 1995 Nov;84(11):898-910.
4
Intracoronary administration of dipyridamole prior to percutaneous transluminal coronary angioplasty provides a protective effect exceeding that of ischemic preconditioning.在经皮腔内冠状动脉成形术之前冠状动脉内给予双嘧达莫可提供超过缺血预处理的保护作用。
Coron Artery Dis. 2000 Dec;11(8):607-13. doi: 10.1097/00019501-200012000-00006.
5
Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
J Am Coll Cardiol. 1996 Nov 1;28(5):1119-26. doi: 10.1016/S0735-1097(96)00307-5.
6
Preconditioning of human myocardium with adenosine during coronary angioplasty.
Circulation. 1997 Jun 3;95(11):2500-7. doi: 10.1161/01.cir.95.11.2500.
7
The effects of intracoronary adenosine on preconditioning during coronary angioplasty.冠状动脉内腺苷对冠状动脉血管成形术期间预处理的影响。
Clin Cardiol. 1995 Feb;18(2):91-6. doi: 10.1002/clc.4960180211.
8
Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment?人类心肌对反复缺血的耐受性发展是由于预处理还是侧支循环的建立?
J Am Coll Cardiol. 1999 Mar 15;33(4):1027-35. doi: 10.1016/s0735-1097(98)00674-3.
9
Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans.无心电图证据表明人类存在缺血预处理和腺苷预处理。
J Am Coll Cardiol. 2003 Aug 6;42(3):437-45. doi: 10.1016/s0735-1097(03)00658-2.
10
Bradykinin-induced preconditioning in patients undergoing coronary angioplasty.冠状动脉成形术患者中缓激肽诱导的预处理
J Am Coll Cardiol. 1999 Sep;34(3):639-50. doi: 10.1016/s0735-1097(99)00297-1.

引用本文的文献

1
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.急性心肌梗死患者在直接经皮冠状动脉介入治疗期间使用腺苷和维拉帕米治疗无复流现象。
Cochrane Database Syst Rev. 2015 May 18;2015(5):CD009503. doi: 10.1002/14651858.CD009503.pub3.